Molecular Mechanisms and Therapy of Gliomas
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 428
Special Issue Editor
Interests: cancer biology; colorectal cancer; neuropathology; surgical pathology; prognostic markers; cancer biomarkers; can-cer diagnostics; molecular biology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In recent years, knowledge of the molecular landscape of gliomas has greatly expanded. It has been shown that histologically similar tumors display distinct epigenetic, genetic, transcriptomic, and proteomic features and that the clinical outcome of gliomas can be better predicted by integrating histological and molecular data rather than by histology. This has led to the development of novel glioma classification schemes. Indeed, the latest World Health Organization Classification of gliomas, published in 2021, subdivided gliomas not only on their growth pattern, that is, diffuse or circumscribed, on their histopathological features and on their anatomical location, but also on genetic alterations. In addition, the essential diagnostic criterion for some tumor types is a unique DNA methylation profile.
An increasing understanding of the molecular features of gliomas has also led to the identification of novel potential therapeutic targets.
This Special Issue aims to collect papers on recent advances in the molecular mechanisms of glioma pathogenesis and progression and on novel therapeutic strategies for these tumors.
Dr. Valeria Barresi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- glioma
- epigenetic
- methylome
- therapy
- genetic alteration
- transcriptomic
- proteomic
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
